Category Archives: Anti-Aging Medicine

Boys and girls, listen up! Were going to separate into two sides: boys on this side, girls on the other. No boys allowed! Are you a boy or a girl? You look like a girl. Those are girl clothes. How many boys are in here? All the girls stand up. This is the girls bathroom! One boy and one girl will be chosen. Boys arent allowed to spend the night.

A couple of years ago, my then seven-year-old son calmly told his dad and me that he no longer wanted to be called a boy. Our son had very long hair at the time and wore skirts or pink clothing on occasion, so hed been mistaken for a girl many times, though it never seemed to bother him. Still, we were surprised. Oh. So then do you want to be called a girl? we asked. He thought for a moment. No, he decided. Because Im neither. Its been almost three years, and Noah is still adamant that he* is non-gendered.

About a year before Noah told us he no longer identified as a boy, he was diagnosed with autism. When I first began writing this post, I was planning to write about misconceptions around ASD and how challenging it can be to raise an atypical kid in a typical world. It was Noah who stopped me.

I think you should write about what its like to be non-gendered in a gender-obsessed world, he argued. Being non-gendered is way harder than having autism. That was a shock. For me, as Noahs mom, managing the symptoms that often accompany autism (like depression, anxiety, and OCD to name a few) seemed way harder than referring to oneself as neither a boy nor a girl. But Noah is living with both and still thinks shaking off gender norms is the most difficult challenge he faces every day.

Im still learning, as Noahs parent, what being gender neutral means for him, and how marginalized nonbinary kids feel every day. The paragraph of expressions at the beginning of this post are some that Noah hears and has to have an immediate response ready for on an almost daily basis. So I asked Noah what three things he wished he could tell the world about being a non-gendered kid, and heres what he said.

With teachers separating the class into boys and girls, boy/girl bathrooms, gendered toy and clothing sections at the store, and girls only or boys only mantras ringing out on the playground, being a nonbinary kid can be a lonely experience.

Is there a non-gendered side? Noah once asked a substitute teacher who insisted boys line up on one side of the room and girls line up on another. The teacher was confused by the question. I asked Noah what he did, and he reported that he was already lining up with the boys even as he asked. If there was a non-gendered side, he said, I would be the only one.

The thing is, trans and gender non-conforming (TGNC) youths are not alone. Multiple studies show that more and more kids are coming out as transgender or rejecting traditional boy/girl gender identities altogether and identifying as gender fluid. According to Daniel Shumer, a specialist in transgender medicine at the University of Michigan, previous estimates of the size of the TGNC population have been underestimated by orders of magnitude. Sadly, pediatric studies are discovering that TGNC kids often have significantly poorer mental and overall health than kids who are cisgender (meaning those with a gender identity which corresponds with their birth sex). Shumer beseeches schools and doctors to abandon limited views of gender for the sake of these kids health and wellbeing. After all, we all remember what its like to be a kid; its lonely enough without being marginalized by an outdated understanding of gender.

Not claiming a gender can be scary and threatening to a kid. Im nervous to wear skirts to school, because most people still think of me as a boy and I dont want to be laughed at, Noah confessed. But wearing skirts at home makes me feel cheerful because theyre pretty.

Unfortunately, being laughed at is mild compared to some of the problems gender non-conforming kids face. According to the Human Rights Campaign, a terrifyingly high percentage of LGBTQ kids are depressed, have trouble sleeping at night, and experience elevated stress as well as feelings of worthlessness and hopelessness. Only 26% of gender expansive youth say they feel safe in their school classrooms, and only five percent say their teachers and school staff are supportive of them. Worst of all, studies have shown that when gender non-conforming kids dont feel supported by their parents, they are at high risks for self-harm, homelessness, and even suicide.

Its not easy being a kid who doesnt adhere to gender normativity. Thats why we adults have to work harder to help gender non-conforming kids feel safe, supported, and loved. I do understand why people are afraid, Noah told me. No one wants to be laughed at. But you should just be who you are. It doesnt matter what anyone else thinks.

The number one thing Noah hears from other kids is, Are you a boy or a girl? I know kids are often just trying to figure things out, but its frustrating for Noah to have to define his gender to every stranger on the playground. Moreover, there are some kids who just cannot let it go. Hes told me stories about kids cornering him at school and harassing him to give them a straight answer about his gender, and by that I mean a black and white answer. In most kids minds there are just two possibilities for gender identity: girl or boy. For non-gendered kids, gender is a box we dont fit inside, Noah explained.

Its our job as adults to teach our kids to be accepting of all people, that gender is not black and white, and that not everyone identifies as a boy or a girl and that is okay. Coincidentally, in my limited experience from helping Noah navigate this, Ive found that knowing someone with an ambiguous gender can be just as challenging for adults as it is for kids. I understand. It can feel slightly uncomfortable not knowing someones gender, especially if we arent sure what pronoun to use when referring to that person. But try to imagine how much more uncomfortable it is for someone who is gender fluid to have to define who they are for every confused person who feels entitled to an answer.

I wish people just didnt care, Noah told me. I wish they wouldnt ask. People dont deserve to be harassed if they say they arent gendered. However, he does have his answer ready when other kids want to know whether Noah is a boy or a girl. He simply asks, Does it matter?

It doesnt matter to me what gender my child is, if any. What does matter to me, as his mother, is that he knows he is loved no matter what. When Noah first told us he was not a boy, obviously we were concerned. We didnt want him to be hurting, and kids who experience gender dysphoria are often in a lot of emotional pain. Could this be why he was struggling with anxiety and depression, and why he was being bullied at school? We sought guidance from Noahs ASD psychologist, who gave me the best advice Ive heard to this day.

There is nothing you can or cannot do or say to make Noah transgender, she told us. He either is trans or he isnt. Your only job is to love him and show him that you support him regardless. If he isnt trans, and hes just experimenting right now, fine. Hell remember that you were always steadfast in your love for and support of him. But if he is trans, he needs your support more than ever, and right now is the time youre showing him whether or not he can trust you.

Our job, as parents, is to love and support our children regardless of where they fall on the gender spectrum. Our job as adults is to educate ourselves and increase our own understanding of a very gender diverse population so we can help build a better world for our kids. Daniel Shumer believes that continued work to build understanding of how youthexpress gender is a critical step toward reducing health disparities in [the TGNC youth] population.

To transgender and gender non-conforming kids, Noahs message is simple: Youre okay. Theres nothing wrong with you. It doesnt matter what anyone else thinks.

As the mother of a non-gendered kid, I hope we can all be as kind and as wise.

*After discussing it at length, we still use the masculine pronoun for Noah, with his consent. He is also fine with she/her pronouns. We havent used they/them, although that is the preferred pronoun for many gender fluid people.

See the original article on ScaryMommy.com

Here is the original post:
3 Things A Non-Gendered Kid Wishes Everyone Knew - Yahoo Lifestyle

Kenya has banned the commercial slaughter of donkeys. The trade-in donkey meat and hide was legalised in 2012, but a report last year warned that the rise of donkey slaughterhouses in Kenya could wipe out all the animals in the country by 2023. Moina Spooner from The Conversation Africa asked Monicah Maichomo to shed more light on the impact of the trade.

What is driving the sudden rise in demand for donkey meat and skins?

The global demand for donkey skins and meat is mostly driven by Chinese markets. In China, donkey meat and skins are used to produce snacks, beauty products, sex stimulants, anti-aging products and traditional medicine known as ejiao.

Ejiao is whats driving demand the most. It consists of gelatin that is extracted from boiled donkey hides. Its claimed to strengthen the blood and generally boost health and vitality. Ejiao has a long tradition in traditional Chinese medicine but previously only the elite in society could afford it. Over the past 30 years, a much larger section of the Chinese population has been able to afford it, driving demand.

Local markets in China cant keep up, so Chinese businesses turned to other sources. Kenya was a good source of donkeys it had about 1.8 million in 2010. And under the law, they are considered a food animal like pigs and cows.

To meet the demand, four export slaughterhouses were licensed and started operating in 2016. These abattoirs had the capacity to slaughter 1,260 donkeys a day. Donkeys are sourced from donkey keepers, others are stolen and some are even brought in (legally and illegally) from Ethiopia to meet the demand.

There are currently no donkey farms in Kenya that have the capacity to supply the slaughterhouses.

What impact is this having and where is it being felt?

The high demand for donkeys has significantly increased their prices, making them hard to find and led to many incidents of donkey theft. The average price of an adult donkey has, in two years, gone up from Ksh4,000 to Ksh13,000.

Also read: Kenyas Marie Stopes Ban May Drive More Women to Unsafe Abortions

Donkeys are also at risk of going extinct in the country. My colleagues and I recently conducted a survey that found that donkeys were being slaughtered at five times the natural reproduction rate. A total of 301,977 donkeys, representing 15% of the donkey population, were slaughtered in four export slaughterhouses between April 2016 and December 2018. Holding all factors constant, we projected that by 2023 there wouldnt be any donkeys left.

This would be a huge blow to many households in Kenya. Poor households depend a lot on working donkeys and have suffered as a result of their scarcity. The households most affected are found in rural Kenya and earn their living from farming.

Donkeys offer crucial services for families that cant afford motorised transport. They provide transport to markets, particularly in remote areas with poor infrastructure. They carry farm produce, people and fodder for other livestock. On a daily basis, theyre used to fetch water and firewood.

Losing a donkey could mean a child has to help with household chores and cant go to school. If a household doesnt own a donkey, it needs to hire one or people to have to take on the tasks. It costs more in terms of both time and money.

Kenya has banned the commercial slaughter of donkeys, for now. What can be done to ensure the system is more sustainable if its reintroduced in the future?

The ban will allow donkey numbers to grow again. If it were reintroduced in the future to ensure a steady, sustainable supply abattoirs should enter into contracts with donkey farmers. Pregnant donkeys should also be excluded from slaughter. At the moment about 27% of females slaughtered are pregnant, disrupting the reproduction rate.

There should also be a focus on donkey breeding research to increase the number and size of donkeys produced. The predominant breeds are descendants and crosses of the Nubian wild ass and the Somali wild ass. Larger breeds could provide more skin and meat.

Kenya could regulate trade more carefully. Other countries in Africa have managed to do this successfully. Ethiopia, for instance, banned the countrys first donkey abattoir from operating, after a public outcry. The government is now looking at more sustainable ways of farming donkeys.

Monicah Maichomo is director, Veterinary Sciences Research Institute, Kenya Agricultural & Livestock Research Organisation.

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read this article:
Why Has Kenya Banned The Commercial Slaughter of Donkeys? - The Wire

GRAND RAPIDS, Mich.--(BUSINESS WIRE)-- Tetra Therapeutics a clinical-stage biopharmaceutical company developing novel treatments for patients with cognitive impairment and memory loss, today announced it has entered into an expanded strategic alliance with Shionogi. The two companies will work together to develop and commercialize BPN14770 for the treatment of Alzheimers disease, Fragile X syndrome and other indications marked by cognitive and memory deficits.

Under the terms of the expanded alliance, Shionogi has increased its equity investment in the company to 50% and has the option to complete a structured buyout of the remaining equity if certain closing conditions are met based on the topline results of the companys clinical Phase 2 PICASSO AD trial in patients with early Alzheimers disease expected to read out later this month.

Tetra is developing BPN14770 for the treatment of brain disorders marked by cognitive and memory impairment including Alzheimers disease and Fragile X syndrome. In addition, Tetra has completed enrollment in a Phase 2 study of BPN14770 in adults with Fragile X syndrome, an indication for which BPN14770 has received Orphan Drug Designation from the U.S. Food and Drug Administration.

This expanded alliance with Shionogi further validates our platform and the potential for BPN14770 to provide a new treatment option for patients suffering from Alzheimers disease, said Mark Gurney, Ph.D., Chairman and Chief Executive Officer of Tetra Therapeutics. We are delighted to be expanding our collaboration with Shionogi and thank them for their continued conviction in our mission. We look forward to announcing topline results from our Phase 2 PICASSO AD trial in Alzheimers disease later this month.

We are pleased to strengthen our strategic alliance with Tetra. With the aging of our society, cognitive disorders are becoming a serious social issue. We believe BPN14770 has the potential to become an innovative new treatment to help solve for this issue. This new collaboration with Tetra reinforces our steadfast commitment to advancing cutting-edge science in central nervous system (CNS) disorders including Alzheimers disease, said Dr. Isao Teshirogi, President and Chief Executive Officer, Shionogi & Co., Ltd.

Cooley LLP, Honigman LLP and Nomura Securities International, Inc., provided advisory services for the transaction.

About BPN14770

BPN14770 is a novel therapeutic agent that selectively inhibits phosphodiesterase-4D (PDE4D) to enhance memory formation in children and older adults. This unique mechanism of action has the potential to improve cognitive and memory function in devastating CNS disorders, including Fragile X syndrome, Alzheimers disease and other dementias, learning/developmental disabilities and schizophrenia. Preclinical animal models show that BPN14770 has the potential to promote the maturation of connections between neurons, which is impaired in patients with Fragile X Syndrome, and to protect connections between neurons which otherwise are lost in patients with Alzheimers disease. Tetra has completed Phase 1 double blind, placebo-controlled, dose-ranging studies of the safety and pharmacokinetics of BPN14770 in healthy volunteers. Evidence of cognitive benefit was found in elderly subjects. Tetra is conducting the PICASSO AD trial, a Phase 2 study of BPN14770 in patients with Alzheimers disease, and an investigational Phase 2 study of BPN14770 in adults with Fragile X syndrome, an indication for which BPN14770 has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA.)

About Tetra Therapeutics

Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products that will bring clarity of thought to people suffering from Fragile X syndrome, Alzheimer's disease, traumatic brain injury, and other brain disorders. Tetra uses structure-guided drug design to discover mechanistically novel, allosteric inhibitors of phosphodiesterase 4 (PDE4), an enzyme family that plays key roles in memory formation, learning, neuroinflammation, and traumatic brain injury. Tetra Therapeutics is headquartered in Grand Rapids, Michigan. For more information, please visit the company's website at http://www.tetratherapeutics.com.

About Shionogi & Co., Ltd.

Shionogi & Co., Ltd. is a major research-driven pharmaceutical company dedicated to bringing benefits to patients based on its corporate philosophy of supplying the best possible medicine to protect the health and wellbeing of the patients we serve. Shionogis research and development currently targets two therapeutic areas: infectious diseases, and pain/CNS disorders. For over 50 years, Shionogi has developed and commercialized innovative oral and parenteral anti-infectives. In addition, Shionogi is engaged in new research areas, such as obesity/geriatric metabolic diseases and oncology/immunology. Contributing to the health and QOL of patients around the world through development in these therapeutic areas is Shionogis primary goal. For more details, please visit http://www.shionogi.co.jp/en/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200306005082/en/

See more here:
Tetra Therapeutics and Shionogi Announce Expanded Alliance - BioSpace

Dr. Catherine DiGiorgio joins the Boston Center for Facial Rejuvenation

BOSTON (PRWEB) March 06, 2020

Leonard Miller, MD, FACS, FRCS is happy to announce the arrival of Board-Certified Dermatologist, Catherine DiGiorgio, MD. The Harvard-trained dermatologist comes into the group with a top-notch education and extensive experience in lasers and cosmetic procedures, most recently working in private practice in Boston, MA and Austin, TX. The Boston Center for Facial Rejuvenation is pleased to add Dr. DiGiorgios unique dermatology expertise and skill to the aesthetic team.

Dr. Miller started his private practice in 1985 and over the last 20 years has built the Boston Center for Facial Rejuvenation into a leading cosmetic surgical and non-surgical treatment facility for the greater Boston area. A pioneer in the field of aesthetic medicine, he was the first doctor to bring the micro-needling procedure to the United States. A board-certified plastic surgeon, over the years, Dr. Miller has perfected several innovative and complex surgical techniques such as the natural facelift and neck rejuvenation. Dr. Miller continues to participate in valuable clinical trials, developing new cosmetic products and skin care technologies.

Dr. Doherty is a board-certified plastic surgeon, specializing in surgical procedures for the breast and body. He joined the Boston Center for Facial Rejuvenation in February of 2015, bringing his talent for creating a pleasing appearance without looking plastic or unnatural. Together, Dr. Miller and Dr. Doherty have been able to provide a wide range of cosmetic surgery procedures for all areas of the face, neck, breast and body.

With two locations, one in Boston and one in Brookline, the Boston Center for Facial Rejuvenation has grown into one of the citys top destinations for surgical and noninvasive cosmetic procedures. As a board-certified dermatologist, Dr. DiGiorgio will bring extensive experience, sharing the teams passion for gentle, natural aesthetic care. She is already an active member of the Boston community and will make an outstanding addition to the Boston Center for Facial Rejuvenation team.

ABOUT DR. CATHERINE DIGIRGIOThe New Orleans native completed her medical training at the Tulane University School of Medicine. This was followed by her internship in Internal Medicine and residency in Dermatology at Louisiana State University Health Sciences Center. Dr. DiGiorgio came to Boston for a competitive fellowship, training at the Harvard Laser and Cosmetic for Photomedicine for 2 years. During this time, she trained in the application of laser and energy-based devices alongside the worlds most respected dermatologists. Today, Dr. DiGiorgio is a speaker and educator, presenting at medical conferences across the U.S., contributing to peer-reviewed journals and textbooks, and participating in dermatology resident education. Before coming to the Boston Center for Facial Rejuvenation, Dr. DiGiorgio practiced dermatology in private practice in Boston and Austin, Texas.

Known for using a conservative approach to dermatology, Dr. DiGiorgio creates a unique treatment plan for every individual. With a gentle bedside manner, she tailors each plan around the patients needs, goals and lifestyle. Dr. DiGiorgio specializes in the use of lasers for semi-invasive and noninvasive procedures. She has extensive experience with Botox and fillers, thread lifts, and microneedling, as well as using PRP growth factors for restoring both skin and hair.

The Boston Center for Facial Rejuvenation welcomes all our patients to consult with Dr. DiGiorgio. She is going to make a wonderful addition to the team. If you would like more information on any of our anti-aging treatments or would like to schedule a consultation appointment with Dr. DiGiorgio, contact the Boston Center for Facial Rejuvenation at 617.735.8735.

Share article on social media or email:

Link:
Dr. Catherine DiGiorgio Joins the Team at the Boston Center for Facial Rejuvenation - PR Web

The Boston Center for Facial Rejuvenation Welcomes Dr. Catherine DiGiorgio to their award-winning practice. Dr. DiGiorgio is a Board-Certified dermatologist, specializing in laser and cosmetic procedures for the face and body. Here she will join two of Boston's finest cosmetic surgeons, Dr. Leonard Miller and Dr. Sean Doherty.

BOSTON, March 4, 2020 /PRNewswire-PRWeb/ --Leonard Miller, MD, FACS, FRCS is happy to announce the arrival of Board-Certified Dermatologist, Catherine DiGiorgio, MD. The Harvard-trained dermatologist comes into the group with a top-notch education and extensive experience in lasers and cosmetic procedures, most recently working in private practice in Boston, MA and Austin, TX. The Boston Center for Facial Rejuvenation is pleased to add Dr. DiGiorgio's unique dermatology expertise and skill to the aesthetic team.

And replace with "Dr. Miller started his private practice in 1985 and over the last 20 years has built the Boston Center for Facial Rejuvenation into a leading cosmetic surgical and non-surgical treatment facility for the greater Boston area. A pioneer in the field of aesthetic medicine, he was the first doctor to bring the micro-needling procedure to the United States. A board-certified plastic surgeon, over the years, Dr. Miller has perfected several innovative and complex surgical techniques such as the natural facelift and neck rejuvenation. Dr. Miller continues to participate in valuable clinical trials, developing new cosmetic products and skin care technologies.

Dr. Doherty is a board-certified plastic surgeon, specializing in surgical procedures for the breast and body. He joined the Boston Center for Facial Rejuvenation in February of 2015, bringing his talent for creating a pleasing appearance without looking plastic or unnatural. Together, Dr. Miller and Dr. Doherty have been able to provide a wide range of cosmetic surgery procedures for all areas of the face, neck, breast and body.

With two locations, one in Boston and one in Brookline, the Boston Center for Facial Rejuvenation has grown into one of the city's top destinations for surgical and noninvasive cosmetic procedures. As a board-certified dermatologist, Dr. DiGiorgio will bring extensive experience, sharing the team's passion for gentle, natural aesthetic care. She is already an active member of the Boston community and will make an outstanding addition to the Boston Center for Facial Rejuvenation team.

ABOUT DR. CATHERINE DIGIRGIO The New Orleans native completed her medical training at the Tulane University School of Medicine. This was followed by her internship in Internal Medicine and residency in Dermatology at Louisiana State University Health Sciences Center. Dr. DiGiorgio came to Boston for a competitive fellowship, training at the Harvard Laser and Cosmetic for Photomedicine for 2 years. During this time, she trained in the application of laser and energy-based devices alongside the world's most respected dermatologists. Today, Dr. DiGiorgio is a speaker and educator, presenting at medical conferences across the U.S., contributing to peer-reviewed journals and textbooks, and participating in dermatology resident education. Before coming to the Boston Center for Facial Rejuvenation, Dr. DiGiorgio practiced dermatology in private practice in Boston and Austin, Texas.

Known for using a conservative approach to dermatology, Dr. DiGiorgio creates a unique treatment plan for every individual. With a gentle bedside manner, she tailors each plan around the patient's needs, goals and lifestyle. Dr. DiGiorgio specializes in the use of lasers for semi-invasive and noninvasive procedures. She has extensive experience with Botox and fillers, thread lifts, and microneedling, as well as using PRP growth factors for restoring both skin and hair.

The Boston Center for Facial Rejuvenation welcomes all our patients to consult with Dr. DiGiorgio. She is going to make a wonderful addition to the team. If you would like more information on any of our anti-aging treatments or would like to schedule a consultation appointment with Dr. DiGiorgio, contact the Boston Center for Facial Rejuvenation at 617.735.8735.

SOURCE Boston Center for Facial Rejuvenation

More here:
Dr. Catherine DiGiorgio Joins the Team at the Boston Center for Facial Rejuvenation - Yahoo Finance

Dublin, March 05, 2020 (GLOBE NEWSWIRE) -- The "Latin America Cosmetic Surgery and Procedure Market 2019-2027" report has been added to ResearchAndMarkets.com's offering.

The Latin American cosmetic surgery and procedure market has been speculated to depict a growth in revenue and expand with a CAGR of 5.23% during the forecasted years 2019-2027.

The cosmetic surgery and procedure market in Brazil is well-established, with the country dominating the entire Latin American region in terms of aesthetic manipulations being performed. The well-defined regulatory structure in the country ensures the safety of treatment provided to patients. The availability of hi-tech devices & products and the affordable prices are helping enhance the market growth. Brazil has mandated all service providers to complete the state-approved aesthetician program and pass an examination in order to obtain license.

The Brazilian Society of Aesthetic Medicine had introduced a program offering anti-cellulite treatments, chemical peels, and laser hair removal to thousands of homemakers and house cleaners free of cost. The philosophy behind launching this initiative was that beauty is everyone's right. The success of this initiative resulted in a significant rise in the popularity of these procedures. In addition, Brazil offers free-of-cost laser hair removal, Botox, and chemical peels for people living below the poverty line and those in need of cosmetic surgery.

Key Topics Covered:

1. Latin America Cosmetic Surgery and Procedure Market - Summary

2. Industry Outlook2.1. Market Definition2.2. Porter's Five Forces Analysis2.2.1. Threat of New Entry2.2.2. Threat of Substitution2.2.3. Buyer's Power2.2.4. Supplier's Power2.2.5. Competitive Rivalry2.3. Key Insights2.4. Value Chain Analysis2.5. Regulatory Framework2.6. Market Attractiveness Index2.7. Market Drivers2.7.1. Rising Medical Tourism in the Developing Economies2.7.2. Increasing Awareness Regarding the Process and Importance of Aesthetic Treatments2.7.3. Rise in Disposable Income2.7.4. Growing Aging Population2.8. Market Restraints2.8.1. Side-Effects Associated With Breast Implants2.8.2. Availability of Substitute Treatments2.8.3. Increase in Explant Procedures2.9. Market Opportunities2.9.1. Increase in the Number of Cosmetic Surgeries2.9.2. Surging Demand for Energy-Based Liposuction Techniques2.10. Market Challenges2.10.1. Reimbursement Issue2.10.2. High Cost of Aesthetic Treatment

3. Cosmetic Surgery and Procedure Market Outlook - by Type3.1. Surgical3.1.1. Breast Augmentation3.1.2. Liposuction3.1.3. Eyelid Surgery3.1.4. Tummy Tuck3.1.5. Breast Lift3.1.6. Other Surgical Types3.2. Non-Surgical3.2.1. Botulinum Toxin3.2.2. Dermal Fillers3.2.3. Laser Hair Removal3.2.4. Chemical Peel3.2.5. Microdermabrasion3.2.6. Photo-Rejuvenation3.2.7. Other Non-Surgical Types

4. Cosmetic Surgery and Procedure Market - Latin America 4.1. Country Analysis4.1.1. Brazil4.1.2. Mexico4.1.3. Rest of Latin America

5. Company Profiles5.1. Candela Corp (Formerly Syneron Medical Ltd)5.2. Sinclair Pharma5.3. Cutera Inc5.4. Galderma (Acquired by Eqt Ab)5.5. Cynosure(Acquired by Hologic)5.6. Sientra Inc5.7. Allergan Inc.5.8. Nestl5.9. Ipsen Pharma5.10. Alma Lasers (Acquired by Shanghai Fosun Pharmaceutical)5.11. Johnson and Johnson Services5.12. Bausch Health (Formerly Valeant)5.13. Lumenis Ltd. (Acquired by Xio) 5.14. Merz

6. Research Methodology & Scope6.1. Research Scope & Deliverables6.1.1. Objectives of Study6.1.2. Scope of Study6.2. Sources of Data6.2.1. Primary Data Sources6.2.2. Secondary Data Sources6.3. Research Methodology6.3.1. Evaluation of Proposed Market6.3.2. Identification of Data Sources6.3.3. Assessment of Market Determinants6.3.4. Data Collection6.3.5. Data Validation & Analysis

For more information about this report visit https://www.researchandmarkets.com/r/gtlz69

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Go here to read the rest:
Outlook into the Latin America Cosmetic Surgery and Procedure Market - CAGR of 5.23% Expected During 2019 to 2027 - GlobeNewswire